Retinoids for ovarian cancer prevention: laboratory data set the stage for thoughtful clinical trials

J Natl Cancer Inst. 2001 Apr 4;93(7):486-8. doi: 10.1093/jnci/93.7.486.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anticarcinogenic Agents / pharmacology*
  • Anticarcinogenic Agents / therapeutic use
  • Clinical Trials as Topic
  • Female
  • Fenretinide / pharmacology
  • Fenretinide / therapeutic use
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Mucin-1 / biosynthesis*
  • Mucin-1 / drug effects*
  • Ovarian Neoplasms / epidemiology
  • Ovarian Neoplasms / metabolism
  • Ovarian Neoplasms / prevention & control*
  • Retinoids / pharmacology*
  • Retinoids / therapeutic use
  • Up-Regulation / drug effects

Substances

  • Anticarcinogenic Agents
  • Mucin-1
  • Retinoids
  • Fenretinide